Burning Rock Publishes 2023 Annual Report on Form 20-F
29 avr. 2024 03h30 HE
|
Burning Rock Biotech Limited
Burning Rock Publishes 2023 Annual Report on Form 20-F
Burning Rock Announces ADS Ratio Change
26 avr. 2024 01h59 HE
|
Burning Rock Biotech Limited
Burning Rock Announces ADS Ratio Change
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
28 mars 2024 17h16 HE
|
Burning Rock Biotech Limited
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
Burning Rock Announces Receipt of Notification from NASDAQ
04 janv. 2024 01h03 HE
|
Burning Rock Biotech Limited
Burning Rock Announces Receipt of Notification from NASDAQ
Burning Rock Announces Results of 2023 Annual General Meeting
19 déc. 2023 21h35 HE
|
Burning Rock Biotech Limited
Burning Rock Announces Results of 2023 Annual General Meeting
Burning Rock Reports Third Quarter 2023 Financial Results
30 nov. 2023 01h25 HE
|
Burning Rock Biotech Limited
Burning Rock Reports Third Quarter 2023 Financial Results
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
22 nov. 2023 02h04 HE
|
Burning Rock Biotech Limited
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
20 nov. 2023 20h55 HE
|
Burning Rock Biotech Limited
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
30 oct. 2023 03h20 HE
|
Burning Rock Biotech Limited
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
15 oct. 2023 19h18 HE
|
Burning Rock Biotech Limited
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test